Results 151 to 160 of about 113,908 (219)

Brief Report: Androgen Receptor Expression Is Associated With Male Predominance in Thymic Neuroendocrine Neoplasms. [PDF]

JTO Clin Res Rep
Nabel CS, Sussman CB, Whittaker CA, Butty VL, Peterson JL, Martin HK, Louissaint A, Bru-Tari E, Chera S, Ligon AH, Yeap BY, Herrera PL, Hung YP.   +12 more
europepmc   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas, Olivia Carere, Lauren Clarfield, Michelle Jacobson   +3 more
wiley   +1 more source

Molecular insights into DDX3X-androgen receptor mRNA regulation via non-canonical G-quadruplex in castration-resistant prostate cancer. [PDF]

Oncogene
Zhang H, Liu TT, Wu F, Colah AN, Ricke EA, Li L, Putnam AA, Ricke WA.   +7 more
europepmc   +1 more source

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

Addiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski, Jason M. Nagata, Suzanne Nielsen   +2 more
wiley   +1 more source

Androgen receptor gene polymorphism and biological age markers in men. [PDF]

Sci Rep
Żelaźniewicz A, Nowak-Kornicka J, Dąbrowski A, Pawłowski B.   +3 more
europepmc   +1 more source

Neuroendocrine Transformation Without PSA Elevation in High-Risk Metastatic Castration-Sensitive Prostate Cancer Under Androgen Receptor Signaling Inhibition: A Case Report. [PDF]

IJU Case Rep
Nakagami Y, Ohnuma S, Tamaoka M, Inoue T, Yamagishi M, Oshinomi K, Nagata M, Oohira Y, Yamochi T, Fukagai T.   +9 more
europepmc   +1 more source

Androgen receptor and fatty acid oxidation cooperate in ferroptosis evasion in BRAFi resistant melanoma. [PDF]

Cell Death Dis
Redondo-Muñoz M, Caballe-Mestres A, Reisz JA, Valero-Leria A, Olias-Arjona A, Aldaz P, D Alessandro A, Wellbrock C, Arozarena I.   +8 more
europepmc   +1 more source

Case Report: First case of synchronous androgen receptor-positive salivary duct carcinoma and prostate adenocarcinoma. [PDF]

Front Surg
Kourou S, Jansen L, Nachtsheim L, van de Loo J, Arolt C, Hieggelke L, Quaas A, Klussmann JP, Mayer M.   +8 more
europepmc   +1 more source